These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1989176)

  • 1. Histocompatibility and other rejection risk factors in cardiac transplantation.
    Zerbe TR; Kormos R; Arena V; Griffith B; Hardesty R; Duquesnoy R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1155-6. PubMed ID: 1989176
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of flow cytometric crossmatching in cardiac transplantation.
    Shenton BK; Glenville BE; Mitcheson AE; Coates E; Talbot D; Givan AL; Kirk A; Dark JH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1153-4. PubMed ID: 1989175
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA antigen mismatching and HLA-specific antibodies in heart transplantation: review of a single center experience. The Manchester Wythenshawe Heart Transplant Team.
    Sheldon S; Dyer PA
    Transplant Proc; 1992 Dec; 24(6):2438. PubMed ID: 1465821
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
    Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation.
    Suberbielle C; Dorent R; Vaissier E; Nataf P; Busson M; Cabrol A; Cabrol C; Charron D; Raffoux C; Gandjbakhch I
    Transplant Proc; 1994 Feb; 26(1):245-6. PubMed ID: 8108959
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
    J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparous women: is routine antibody screening enough in cardiac transplantation?
    Miller LW; Phelan DL; Noedel N; McBride LR; Pennington DG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1135-6. PubMed ID: 1989169
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic mechanisms of cardiac transplant rejection.
    Duquesnoy RJ; Cramer DV
    Cardiovasc Clin; 1990; 20(2):87-103. PubMed ID: 2404607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
    Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
    Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
    Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
    J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of pediatric heart transplantation: a clinical update.
    Webber SA
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():158-84. PubMed ID: 11460982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes.
    Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical manifestations of vascular rejection in cardiac transplantation.
    Ensley RD; Hammond EH; Renlund DG; Yowell RL; Bristow MR; DeWitt CW; Menlove RL; Ratkovec RM; O'Connell JB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1130-2. PubMed ID: 1989167
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of cytotoxic antidonor HLA antibodies and mismatched marrow graft rejection.
    Ting A; Pun A; Atkinson K; Dodds A; Biggs J
    Transplant Proc; 1986 Apr; 18(2):264-6. PubMed ID: 3515662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.